Stay updated on TransCon IL-2 β/γ Clinical Trial

Sign up to get notified when there's something new on the TransCon IL-2 β/γ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TransCon IL-2 β/γ Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T18:13:46.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0 from the history.
    Difference
    0.1%
    Check dated 2026-04-18T13:23:47.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 in the page history.
    Difference
    0.1%
    Check dated 2026-03-20T19:51:20.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 added and Revision: v3.4.2 removed from the version list.
    Difference
    0.1%
    Check dated 2026-03-13T19:12:54.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Recruiting was removed and Active, not recruiting was added; new sections for Contacts/Locations, Study Design, Study Status, and Recruitment Status were introduced.
    Difference
    0.6%
    Check dated 2026-02-26T09:44:57.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Version History now includes a new entry 'Revision: v3.4.2' and removes 'Revision: v3.4.1', indicating a page update to the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:49:54.000Z thumbnail image

Stay in the know with updates to TransCon IL-2 β/γ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TransCon IL-2 β/γ Clinical Trial page.